Science 37

Science 37 is making the promise of virtual trials the new reality. By engaging with patients from the comfort of their own home, the company provides access to patients who can never be reached by traditional site-based research models. Its virtual model has proven to enroll faster, retain patients at a higher rate, and reach a more representative patient population. Science 37 has conducted more virtual (or decentralized), interventional trials than any other company, using an expansive, in-house network of telemedicine investigators and home-health nurses. The company's research is powered by the industry’s most comprehensive, fully integrated clinical trial platform purpose-built to conduct virtual trials.

Science 37 headquartered in United States, North America, operates in the Biotechnology, Health Care, Clinical Trials, Home Health Care sector. The company focuses on Biotechnology and has secured $33.4B in funding across 96 round(s). With a team of 251-500 employees, Science 37 is actively contributing to advancements in Biotechnology. Their latest funding round, Series A - Science 37, raised $6.5M. Discover more about their projects, partnerships, and impact on our platform.